الملخص
Aims@#This study was aimed to investigate the anti-inflammatory and anti-rheumatoid effects of the Bacillus amyloliquefaciens derived surfactin.@*Methodology and results@#Crude and biosurfactant extracts were analyzed using thin-layer chromatography to determine the presence of biosurfactant. Both extracts were evaluated for their inhibitory effects against the acetylcholinesterase and 5-lipoxygenase enzymes. Human synovial cells were induced with TNF-α and IL-1β. The percentages of the cell viability for both normal and induced cells were determined with an MTT assay. Results showed that surfactin was detected in the biosurfactant extract and demonstrated higher inhibitory effects compared to the crude extract against both inhibitory enzymes acetylcholinesterse (IC50=30.60 μg/mL) and lipoxygenase (IC50=110.10 μg/mL). Both crudes showed no cytotoxic effects at the highest concentration used (50 μg/mL) against normal human synovial cells but showed active reactions against the induced cells. The anti-proliferative effects of biosurfactant and crude extracts were in dose-dependent manner.@*Conclusion, significance and impact of study@#Notably, surfactin obtained from B. amyloliquefaciens has shown an inhibitory effect against pro-inflammatory enzymes and cell viability of the induced rheumatoid arthritis cell line. These results highlighted the therapeutic potential of surfactin application as an anti-inflammatory agent for arthritis treatment. Further study is needed to elucidate the mechanisms underlying the anti-inflammatory effect of surfactin.
الموضوعات
Bacillus amyloliquefaciens , Surface-Active Agents , Anti-Inflammatory Agents , Rheumatoid Factorالملخص
OBJECTIVE@#To analyze the differences of clinical manifestations and laboratory features between primary Sjögren's syndrome (pSS) patients with positive and negative anti-Sjögren's syndrome type B (SSB) antibody.@*METHODS@#The clinical data of pSS patients hospitalized in Department of Rheumato-logy and Immunology, Peking University Third Hospital were retrospectively analyzed to investigate the differences of clinical and laboratory features between anti-SSB positive and negative groups. The t test, Mann-Whitney U test, Chi-square test and Fisher's exact probability were used for analysis.@*RESULTS@#A total of 142 pSS patients were enrolled in this study, including 137 females and 5 males with a mean age of (54.8±13.3) years. The anti-SSB positive group included 44 patients accounting for 31.0% of the pSS patients. The anti-SSB positive pSS patients were younger at disease onset and at visit [age at visit: (50.9±14.5) years vs. (56.5±12.4) years; age at onset: (42.2±14.8) years vs. (49.5±15.3) years, P < 0.05]. The patients with anti-SSB positive more frequently presented with rash (29.5% vs. 14.3%, P < 0.05), enlargement of parotid glands (27.3% vs. 8.2%, P < 0.05), renal tubular acidosis (15.9% vs. 4.2%, P < 0.05), immune thrombocytopenia (9.1% vs. 1.0%, P < 0.05), rheumatoid factor (RF) positive (85.0% vs. 49.4%, P < 0.05), higher RF and antinuclear antibody (ANA) titers (median: 89.8 IU/mL vs. 20.5 IU/mL; median: 320 vs. 160, P < 0.05), anti-Sjögren's syndrome type A (SSA) antibody positive (97.7% vs. 64.3%, P < 0.05), elevation of γ globulin (71.4% vs. 38.5%, P < 0.05), higher levels of IgG (median: 21.0 g/L vs. 15.6 g/L, P < 0.05), higher proportions of CD3-CD19+ cells [(21.0±11.9)% vs. (13.7±9.6)%, P < 0.05] and lower proportions of CD3+ cells [(67.2±14.4)% vs. (76.6%±13.1)%, P < 0.05] than those negative. However, the anti-SSB positive group was less likely to show anti-mitochondrial antibodies (AMA)-M2 positivity (10.5% vs. 35.6%, P < 0.05). Glucocorticoids (90.9% vs. 73.5%, P < 0.05) and immunosuppressants (54.5% vs. 36.7%, P < 0.05) were more frequently used in anti-SSB positive pSS patients than those negative.@*CONCLUSION@#The anti-SSB positive pSS patients were younger at disease onset while more frequently presenting with various symptoms, higher levels of other antibodies and activation of B cells than those negative. Glucocorticoids and immunosuppressants were more frequently used, indicating that anti-SSB positive group presented with a more severe clinal phenotype.
الموضوعات
Adult , Aged , Female , Humans , Male , Middle Aged , Antibodies, Antinuclear , Immunosuppressive Agents , Retrospective Studies , Rheumatoid Factor , Sjogren's Syndrome/complicationsالملخص
Introducción: La artritis reumatoide es una enfermedad autoinmune de causas desconocidas en la que pueden influir distintas alteraciones genéticas. Se describen casos seropositivos con mayor riesgo de padecer manifestaciones extraarticulares y complicaciones de la enfermedad. Objetivo: Identificar la relación existente entre las alteraciones genéticas y la positividad de autoanticuerpos en pacientes con diagnóstico de artritis reumatoide. Métodos: Investigación básica, no experimental, transversal y descriptiva de un universo de 157 pacientes con diagnóstico de artritis reumatoide según los criterios del Colegio Americano de Reumatología. La muestra quedó conformada por 113 pacientes. Como parte del seguimiento de laboratorio de cada paciente se determinó anticuerpos tipo factor reumatoide y antipéptido citrulinado cíclico. Se realizó el estudio genético para identificar HLA-DR3 y HLA-DR4. Se utilizó la prueba no paramétrica de correlación de Pearson para determinar correlación entre el patrón genético y la seropositividad en estos pacientes. Resultados: Promedio de edad de 58,74 años con predominio de pacientes femeninas (72,57 por ciento). El 38,05 por ciento presentó al menos una comorbilidad asociada. El factor reumatoide fue positivo en el 60,18 por ciento de los pacientes, mientras que el antipéptido citrulinado cíclico positivo se identificó en el 41,59 %. Se halló alteraciones del patrón genético en el 66,37 por ciento de los pacientes; el HLA-DR4 estuvo presente de forma independiente en el 38,67 por ciento de los casos positivos y combinado con el HLA-DR3 en el 20,66 por ciento. Conclusión: Se identificó una correlación positiva considerable entre las alteraciones del patrón genético y la seropositividad. La presencia de alteraciones del patrón genético triplica el riesgo de seropositividad en los pacientes con artritis reumatoide(AU)
Introduction: Rheumatoid arthritis is an autoimmune disease of unknown causes in which the presence of different genetic alterations is invoked. Seropositive cases with a higher risk of appearance of extra-articular manifestations and complications of the disease are described. Objective: To identify the relationship between the presence of genetic alterations and autoantibody positivity in patients diagnosed with rheumatoid arthritis. Methods: Basic, non-experimental, cross-sectional and descriptive research with a universe of 157 patients diagnosed with rheumatoid arthritis according to the criteria of the American College of Rheumatology. The sample was made up of a total of 113 patients. As part of the laboratory follow-up of each patient, the presence of rheumatoid factor and anti-cyclic citrullinated peptide antibodies was determined, and a genetic study was performed to identify the presence of HLA-DR3 and HLA-DR4. The nonparametric Pearson's correlation test was used to determine the correlation between the identification of HLA types and seropositivity in patients with rheumatoid arthritis. Results: Average age of 58.74 years with a predominance of female patients (72.57%). 38.05 percent presented at least one associated comorbidity. Rheumatoid factor was positive in 60.18 percent of the patients, while positive anti-cyclic citrullinated peptide was identified in 41.59 percent of the cases studied. Genetic pattern alterations were identified in 66.37 percent of the patients; HLA-DR4 was present independently in 38.67 percent of the positive cases and combined with HLA-DR3 in 20.66 percent. Conclusion: A considerable positive correlation was identified between alterations in the genetic pattern and seropositivity. The presence of genetic pattern alterations triples the risk of seropositivity in patients with rheumatoid arthritis(AU)
الموضوعات
Humans , Arthritis, Rheumatoid/diagnosis , Rheumatoid Factor/analysis , Anti-Citrullinated Protein Antibodies/analysis , Arthritis, Rheumatoid/geneticsالملخص
Introducción: Los anticuerpos contra el citoplasma del neutrófilo se detectan normalmente en pacientes con vasculitis. Aunque estos anticuerpos pueden estar presentes en un amplio número de enfermedades asociadas a estados inflamatorios y autoinmunes, como la artritis reumatoide, no se ha demostrado su significado clínico. Objetivo: evaluar la utilidad de diferentes especificidades antigénicas de los anticuerpos contra el citoplasma del neutrófilo para medir la actividad clínica en pacientes cubanos con artritis reumatoide. Material y Métodos: Se realizó un estudio transversal con 77 pacientes cubanos con artritis reumatoide. Se determinaron la velocidad de sedimentación globular, la proteína C reactiva, el indicador clínico de actividad de la enfermedad, los anticuerpos anti-proteínas citrulinadas, el factor reumatoide y los anticuerpos contra el citoplasma del neutrófilo frente a diferentes especificidades antigénicas. Resultados: La mayor cantidad de pacientes con actividad clínica elevada (> 5,1) pertenecieron al grupo de pacientes positivos de anticuerpos contra el citoplasma del neutrófilo (p=0,0364). Los pacientes con anticuerpos anti-lactoferrina tuvieron mayores valores de actividad clínica (p=0,0304). Mediante análisis multivariado se demostró la influencia de la positividad de anticuerpos anti-lisozima (p=0,0391), de la positividad doble de los anticuerpos anti-proteínas citrulinadas y anti-lactoferrina (p=0,0282), así como de la doble positividad de los anticuerpos anti-proteínas citrulinadas y anti-elastina (p=0,0182) en la actividad clínica. Conclusión: La presencia de anticuerpos contra el citoplasma del neutrófilo que reconocen las especificidades antigénicas lisozima, lactoferrina y elastina se relacionan con mayor actividad clínica en pacientes con artritis reumatoide(AU)
Introduction: Antibodies against neutrophil cytoplasm are normally detected in patients with vasculitis. Although these antibodies can be present in a wide number of diseases associated with inflammatory and autoimmune conditions such as rheumatoid arthritis, their clinical significance has not been demonstrated. Objective: To evaluate the usefulness of different antigenic specificities of antibodies against neutrophil cytoplasm to measure the clinical activity in Cuban patients with rheumatoid arthritis. Material and Methods: A cross-sectional study was conducted on 77 Cuban patients with rheumatoid arthritis. Erythrocyte sedimentation rate, C-reactive protein, the clinical indicator of disease activity, anti-citrullinated protein antibodies, rheumatoid factor, and antibodies against neutrophil cytoplasm against different specificities were determined. Results: The largest number of patients with elevated disease activity (> 5.1) belonged to the group of antibodies against neutrophil cytoplasm positive patients (p=0.0364). Patients with anti-lactoferrin antibodies had higher disease activity values (p=0.0304). Through multivariate analysis, the influence of positive anti-lysozyme antibodies (p=0.0391), of double positivity of anti-citrullinated protein and anti-lactoferrin antibodies (p=0.0282), as well as that of double positivity of anti-citrullinated protein and anti-elastin antibodies (p=0.0182) on disease activity were demonstrated. Conclusion: The antibodies against neutrophil cytoplasm that recognize the antigenic specificities of lysozyme, lactoferrin and elastin are related to higher clinical activity in patients with rheumatoid arthritis(AU)
الموضوعات
Humans , Male , Female , Arthritis, Rheumatoid , Rheumatoid Factor , Anti-Citrullinated Protein Antibodies , Cross-Sectional Studiesالملخص
Introducción: La COVID-19 es una enfermedad que causa alteraciones del sistema inmunitario. Estas pueden afectar el perfil inmunológico de las enfermedades reumáticas. Objetivo: Identificar el comportamiento del perfil inmunológico de los pacientes con enfermedades reumáticas en los cuales se confirmó el diagnóstico de COVID-19. Métodos: Se realizó una investigación básica con elementos de investigación clínica de 116 pacientes con enfermedades reumáticas, según los criterios del American College of Rheumatology, diagnosticados con COVID-19 entre mayo y diciembre del 2020 y atendidos en unidades asistenciales de la ciudad de Riobamba en Ecuador. Se determinaron los valores del perfil inmunológico en relación con la enfermedad reumática de base en el momento del diagnóstico de la COVID-19, y transcurridos los 7, 15, 30 y 90 días del diagnóstico de la afectación respiratoria. Resultados: Se identificó aumento del factor reumatoide en el 76,31 por ciento de los casos con artritis reumatoide a los 30 días del diagnóstico de COVID-19. El 18,18 por ciento de los pacientes con espondiloartropatías presentó factor reumatoide positivo a partir de los 15 días del diagnóstico de la enfermedad respiratoria. Aumentaron los pacientes con lupus y consumo de complemento y pacientes con síndrome de Sjögren y positividad de anti-SSa (61,54 por ciento ) y anti-SSb (41,15 por ciento ). Conclusiones: La COVID-19 causa cambios en el perfil inmunológico de los pacientes con enfermedades reumáticas: positividad de anticuerpos y consumo de complemento, y evoluciona de manera irregular en la positividad del factor reumatoide en pacientes con espondiloartropatías. La mayoría de las alteraciones inmunitarias se mantienen hasta 90 días después del diagnóstico de la COVID-19(AU)
Introduction: COVID-19 is a disease that generates alterations of the immune system. These can affect the immune profile of rheumatic diseases. Objective: To identify the behavior of the immunological profile of patients with rheumatic diseases in whom the diagnosis of COVID-19 was confirmed. Methodology: A basic research was carried out including elements of clinical research. Universe made up of 116 patients with rheumatic diseases, according to the criteria of the American College of Rheumatology, and COVID-19. Immunological profile values ―were determined in relation to the underlying rheumatic disease at the time of diagnosis of COVID-19, and after 7, 15, 30 and 90 days after the diagnosis of respiratory involvement. Results: An increase in rheumatoid factor was identified in up to 76.31 percent of the cases with rheumatoid arthritis 30 days after diagnosis of COVID-19. 18.18 percent of the patients with spondyloarthropathies presented positive RF after 15 days of diagnosis of the respiratory disease. There was an increase in patients with lupus and supplement consumption and patients with Sjögren's syndrome and positivity of anti-SSa (61.54 percent) and anti-SSb (41.15 percent). Conclusions: COVID-19 generates changes in the immunological profile of patients with RD due to antibody positivity and complement consumption; even behaving irregularly in the case of RF positivity in patients with AD. Most immune alterations persist for up to 90 days after COVID-19 diagnosis(AU)
الموضوعات
Humans , Male , Female , Arthritis, Rheumatoid/complications , Rheumatoid Factor , Rheumatology , Autoantibodies , Rheumatic Diseases , COVID-19/complicationsالملخص
Introducción: La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo donde ocurre inicialmente la vasculopatía y persiste durante toda la enfermedad. El índice de actividad revela un periodo crítico de la enfermedad. Objetivo: Evaluar la evolución clínica del índice de actividad de pacientes con esclerosis sistémica para determinar si el esquema terapéutico aplicado disminuye los síntomas de actividad sistémica. Métodos: Estudio cuasi experimental terapéutico de 31 pacientes atendidos en el Hospital Lucía Íñiguez Landín de Holguín que se dividieron en dos grupos según las etapas clínicas obtenidas del índice de desarrollo integral desde marzo del 2013 hasta marzo del 2016: el grupo A (etapas clínicas I y II) con 16 pacientes y el grupo B (etapas clínicas III y IV) con 15 pacientes. La evolución se evaluó según variables del instrumento al inicio, a los 6 y 12 meses de aplicado el esquema terapéutico. Se utilizó la prueba T o la prueba exacta de Fisher cuando los valores eran igual a 3 o menores. El cálculo de la media, análisis porcentual y la prueba de Wilcoxon se usaron para conocer la relación de variables en el tiempo. Resultados: El esquema terapéutico aplicado, previa validación, mejoró el índice de actividad de los pacientes de ambos grupos A y B (en etapas clínicas tempranas y tardías). Al evaluar el índice de actividad, en esta serie predominó la actividad moderada, tanto a los 6 como a los 12 meses durante el tratamiento médico. En ambos grupos la mejoría del índice de actividad fue significativa, tanto para la actividad moderada como para la intensa, más notable a partir de los 12 meses con p≤0,05 para el grupo A. Hubo baja susceptibilidad para la mejoría de los sistemas gastrointestinal y respiratorio, en el trascurso de la evaluación de este índice. Conclusiones: Se alcanzó mejoría en el índice de actividad de pacientes con esclerosis sistémica, con el esquema terapéutico aplicado, con estabilidad clínica y humoral desde las etapas iniciales de la enfermedad(AU)
Introduction: The systemic sclerosis is an autoimmune disease of the connective tissue where the vasculopathy happens initially and persist during all the disease. The immune component starts since the inflammatory process triggers off but he diminishes until you dwell on the evolutionary course and it is substituted for fibrosis, this ends pathogenic acquires great significance in the process. The index of activity reveals a critical period of the disease. Objective: Evaluating patients' clinical evolution of the index of activity with systemic sclerosis with the applied therapeutics. Methods: The study was quasi-experiences (or secondary prevention). In order to determine if the therapeutic applied scheme decreases symptomatology of its systemic activity. You started in March of the 2013 to March of the 2016, with duration of 24 months. They were 31 patients that split into two groups according to the clinical stages obtained of Comprehensive Development Index. In the group to (clinical stages I and II) 16 patients and in the group B (clinical stages III and IV) 15 patients. The evolution evaluated according to variables of the instrument of evaluation the start, to the six and 12 months itself of once the therapeutic scheme was applied. The T utilized the proof itself, or exact Fisher's proof when moral values were all the same or minor to three, the statistical significance determined in p≥ 0.05 itself. The calculation of the stocking, percentage analysis, and Wilcoxon's proof to know the relation of variables through the time. Results: The therapeutic applied scheme, previous validation, you improved the index of activity of the patients of both groups A and B that is in clinical premature and overdue stages. In the activity moderated for the group A statistical significance for system microvascular (0.023) and respiratory (0.025) to the six months, and to the 12 months' skin (0.023) and microvascular (0.006). For the intense activity significant improvement to the six months for muscleskelettic (0.005) and rheumatoid positive factor (0.008), to the 12 months' significant improvement for muscleskelettic (0.004); and examine of laboratory like erythrocyte sedimentation rate (0.008) circulating immune complexes (0.005), and rheumatoid factor (0.003). For the group B in the moderate activity significant improvement for respiratory system existed (0.014), and cardiovascular (0.020) that kept to the 12 months, added up its digestive system (0.008). Evident level improvement of skin (0.004), circulating immune complexes (0.008) and rheumatoid factor were caught up within the intense activity to the 12 months (0.014). Conclusions: Improvement in the index of activity of patients with systemic sclerosis, with the therapeutic scheme applied, with clinical stability and humoral from initial stages of the disease was caught up with(AU)
الموضوعات
Humans , Male , Female , Rheumatoid Factor , Scleroderma, Systemic/drug therapy , Prednisone/therapeutic use , Clinical Evolution , Cyclophosphamide/therapeutic use , Disease Susceptibility , Antigen-Antibody Complex , Secondary Preventionالملخص
Rheumatoid arthritis is an autoimmune inflammatory joint disease with global prevalence of 0.4% to 1.0%. Extra-articular manifestations increase its morbidity and severity, and cardiovascular diseases present the greatest risk. Therapeutic approaches have been used to treat rheumatoid arthritis, often involving the use of multiple classes of drugs with different mechanisms and forms of action. Corticosteroid therapy is widely used in this therapeutic combination; however, its use has been widely questioned because of its high toxicity and some negative effects, including the possibility of increased cardiovascular risk, depending on the dosage. Some studies have provided important insights into how glucocorticoids have an impact on cardiac complications in patients with rheumatoid arthritis. Most of these studies have concluded that exposure to these drugs at high or cumulative doses is associated with increased risk of death, as well as possibly being associated with the presence of a positive rheumatoid factor.
الموضوعات
Arthritis, Rheumatoid/complications , Cardiovascular Diseases/complications , Heart Disease Risk Factors , Glucocorticoids/adverse effects , Patients , Rheumatoid Factor , Pharmaceutical Preparations , Homeopathic Therapeutic Approachesالملخص
Este relato teve como objetivo apresentar um caso de elderly onset rheumatoid arthritis associada à trombocitose reacional significativa. À admissão, o paciente apresentava quadro de poliartrite de pequenas e grandes articulações associado à rigidez matinal. Após exames solicitados, evidenciaram-se trombocitose de 1.697.000 cel./mm³ e anticorpos antipeptídeos citrulinados positivos, sendo diagnosticado com artrite reumatoide do tipo elderly onset rheumatoid arthritis.
This report aimed at presenting a case of elderly-onset rheumatoid arthritis associated with significant reactive thrombocytosis. On admission, the patient presented polyarthritis of small and large joints associated with morning stiffness. After the performance of the requested tests, thrombocytosis of 1,697,000 cells/mm3 and positive anti-CCP were evidenced, and the patient was diagnosed with elderly-onset rheumatoid arthritis.
الموضوعات
Humans , Male , Middle Aged , Arthritis, Rheumatoid/diagnosis , Thrombocytosis/diagnosis , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/blood , Rheumatoid Factor/analysis , Thrombocytosis/complications , Thrombocytosis/blood , Blood Cell Count , Blood Sedimentation , C-Reactive Protein/analysis , Edema/etiology , Anti-Citrullinated Protein Antibodies/isolation & purificationالملخص
A doença de Still do adulto é uma rara condição inflamatória, cujo diagnóstico é um desafio, por se tratar de diagnóstico de exclusão, após vasta investigação. Manifesta-se com febre alta diária, amigdalite não supurativa, artrite, rash evanescente, leucocitose e hiperferritinemia. O presente caso demonstra a doença de Still do adulto e sua vasta investigação, motivando a realização de revisão bibliográfica sobre inovações na fisiopatologia, no diagnóstico e no tratamento.
Adult onset Still's disease is a rare inflammatory condition, the diagnosis of which is a challenge, because it is a diagnosis of exclusion, and demands extensive investigation. It manifests with high daily fever, nonsuppurative tonsillitis, arthritis, evanescent rash, leukocytosis, and hyperferritinemia. The present case demonstrates adult-onset Still's disease and its extensive investigation, motivating literature review on innovations of its pathophysiology, diagnosis, and treatment.
الموضوعات
Humans , Female , Adult , Young Adult , Still's Disease, Adult-Onset/diagnosis , Aspartate Aminotransferases/blood , Rheumatoid Factor/blood , Splenomegaly , Blood Sedimentation , C-Reactive Protein/analysis , Pharyngitis , Rheumatic Diseases/diagnosis , Still's Disease, Adult-Onset/drug therapy , Adrenal Cortex Hormones/therapeutic use , Arthralgia , Antirheumatic Agents/therapeutic use , Rare Diseases/diagnosis , Diagnosis, Differential , Alanine Transaminase/blood , Exanthema , Fever , Hyperferritinemia/blood , Infections/diagnosis , Leukocytosis/blood , Neoplasms/diagnosisالملخص
OBJECTIVE@#To explore the clinical characteristics and biological treatment of juvenile Idiopathic arthritis (JIA) after adulthood.@*METHODS@#Selected 358 patients with previous medical history diagnosed by JIA who were hospitalized in the Department of Rheumatology and Immunology, West China Hospital of Sichuan University from January 1, 2009 to January 1, 2019. Perform retrospective analysis of basic information, clinical symptoms, diagnostic indicators, treatment plans, outpatient follow-up (inpatients require outpatient follow-up treatment) and diagnosis and treatment process of 90 eligible cases included, and observe different ages and different courses of disease. The clinical characteristics of young and middle-aged idiopathic arthritis in adults and the outpatient situation of using biological agents for 6 months.@*RESULTS@#According to age, they were divided into ≤26 years old group (42 cases) and >26 years old group (48 cases). Under examination [rheumatoid factor (RF), anti-nuclear antibody (ANA), anti-neutrophil antibody (ANCA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), interleukin-1β (IL-1β), interleukin 6 (IL-6), hemoglobin (HGB), white blood cell count (WBC), human leukocyte antigen-B27 (HLA-B27), complement 3 (C3), etc.], concurrent in terms of symptoms, treatment and prognosis, the ≤26-year-old group was generally lighter than the >26-year-old group; that was, the older the age, the heavier the onset of inflammation and other symptoms, the more complications, the worse the treatment effect, and the worse the prognosis, and there were statistical differences academic significance (P < 0.05). According to the course of disease, they were divided into ≤19 years group (46 cases) and >19 years group (44 cases). In terms of examination (RF, ANA, ANCA, ESR, CRP, IL-1β, IL-6, HGB, HLA-B27, C3, etc.), complications, treatment and prognosis, the course of disease ≤19 years group was compared with the disease course> 19 years group Overall mild; that was, the longer the course of the disease, the more severe the onset of symptoms such as inflammation, the more complications, the worse the treatment effect, and the worse the prognosis, P < 0.05, the difference was statistically significant. After 6 months of outpatient treatment with biological agents, it was found that biological agents could improve some of the patients' clinical symptoms and delay the further development of the disease. Compared with the non-biological agent treatment group (48 cases), the biological agent group (42 cases) benefited, and the difference was statistically significant (P < 0.05).@*CONCLUSION@#Through retrospective analysis, this article believes that although adult JIA is diagnosed as connective tissue disease, it has special clinical characteristics with the course of the disease and age. Therefore, it should be recommended to give special attention to JIA patients after adulthood, require regular medical treatment in the adult rheumatology department, according to the corresponding connective tissue disease or JIA diagnosis, and standard treatment; at the same time, pay attention to the history of JIA. In the comparison of biological and non-biological treatment, it is proved that biological treatment can effectively improve some of the clinical symptoms of JIA patients after adulthood. Therefore, it is recommended that biological treatment be used as soon as possible if economic conditions permit to delay the development of the disease.
الموضوعات
Adult , Humans , Infant , Middle Aged , Arthritis, Juvenile/drug therapy , Blood Sedimentation , China , Retrospective Studies , Rheumatoid Factorالملخص
OBJECTIVE@#To analyse the clinical and laboratory characteristics of antinuclear antibody (ANA) positive rheumatoid arthritis (RA) patients.@*METHODS@#The clinical and laboratory data of 428 RA cases from Department of of Rheumatology and Immunology Peking University Third Hospital from Jan 2013 to Dec 2018 were collected and used to analyse characters between ANA positive group and ANA negative group. T test was used for the quantitative data in accordance with normal distribution. Wilcoxon rank sum test was used for the quantitative data of non normal distribution. The qualitative data were analyzed by chi square test. But while 1≤theoretical frequency < 5, chi square test of corrected four grid table was used. And Fisher exact probability method was used when theoretical frequency < 1.@*RESULTS@#The number of ANA positive group was 231 (54%). The female rate was obviously higher in ANA positive group (82.7% vs. 63.5%, χ2=20.355, P < 0.01). The rate of metatarsophalangeal joints (MTPJs) involvement was lower in ANA positive group (22.1%) than in ANA negative group (33.0) (χ2=6.414, P < 0.05). The incidence of secondary Sjögren's syndrome (sSS) was much higher in ANA positive group(19.5% vs. 4.1%, χ2=23.300, P < 0.01). The positivity of rheumatoid factor (RF), as well as the positivity of anti-cyclic citrullinated peptide(CCP) antibody was much higher in ANA positive group (77.1% vs. 53.8%, χ2=25.743, P < 0.01, 74.9% vs. 59.4%, χ2=11.694, P < 0.01, respectively). The levels of immunoglobulin G (IgG) and immunoglobulin M (IgM) of ANA positive group were higher [(15.1±5.1) g/L vs. (13.8±5.3) g/L, t=2.359, P < 0.05, 1.25 (0.92) g/L vs. 1.05 (0.65) g/L, Z=-3.449, P < 0.01, respectively]. But the levels of hemoglobin (Hb) and platelet (PLT) was lower in ANA positive group[(109.64±17.98) vs. (114.47±18.48) g/L, t=-2.734, P < 0.01; (266.4×109±104.6×109) vs. (295.9×109±100.1×109) /L, t=-2.970, P < 0.01, respectively].@*CONCLUSION@#The incidence of sSS was obviously higher in ANA positive group than in ANA negative group. Serum IgG of ANA positive group was higher, but Hb and PLT were lower.
الموضوعات
Female , Humans , Antibodies, Antinuclear , Arthritis, Rheumatoid/epidemiology , Autoantibodies , Laboratories , Peptides, Cyclic , Rheumatoid Factorالملخص
OBJECTIVE@#To investigate the clinical characteristics and high risk factors of Rheumatoid arthritis (RA) complicated with tuberculosis infection.@*METHODS@#Patients with rheumatoid arthritis diagnosed in the hospital of Sichuan Provincial People's Hospital from January 2007 to January 2017 was retrospectively collected, who were enrolled in the study group. A control group was randomly selected from the RA patients hospitalized in the same period without co-infection at a ratio of 1 :2. The general data, clinical data, laboratory test data, treatment plan, etc. of the two groups were collected in detail for single factor statistical analysis. Then multivariate Logistic regression was used to analyze the independent risk factors of RA complicated with tuberculosis infection with statistical significance in univariate analysis.@*RESULTS@#The clinical manifestations of fever (83.3%) were most common, followed by cough (69%) and body mass loss (45.2%). In the infected group, pulmonary tuberculosis accounted for 73.3%. In the infected group the chest CT showed two or more cases, accounting for 59%. There were 9 cases (33.3%) occurring in the typical tuberculosis occurrence site. Compared with the control group, the erythrocyte sedimentation rate (ESR), C-reaction protein (CRP) levels, and the daily average dose of glucocorticoid in 1 year in the infected group were higher than those in the control group. And those differences were statistically significant(P < 0.05). There were no significant differences in gender, age, disease duration, disease activity score, white blood cell (WBC), platelet (PLT), hemoglobin (Hb), immunoglobulin G (IgG), complement (C), Anti cyclic citrullinated peptide antibody (anti-CCP), CD4+T cell count, and immunosuppressant use (P > 0.05). Multivariate Logistic regression analysis showed that CRP levels(OR=1.016, 95%CI:1.002-1.031) and the daily average dose of glucocorticoid in 1 year(OR=1.229, 95%CI:1.066-1.418)were the independent risk factors of RA complica-ted with tuberculosis infection.@*CONCLUSION@#RA patients with tuberculosis infection are mainly phthisis. The clinical manifestations of RA combined with tuberculosis infection are lack of specificity, and the chest imaging features of pulmonary tuberculosis are diverse, which are easy to be misdiagnosed. CRP levels and the daily average dose level of glucocorticoid in 1 year were risk factors for RA and tuberculosis infection.
الموضوعات
Humans , Arthritis, Rheumatoid/complications , Autoantibodies , Blood Sedimentation , Peptides, Cyclic , Retrospective Studies , Rheumatoid Factor , Tuberculosis/epidemiologyالملخص
OBJECTIVE@#To detect the levels of Dickkopf-1 (DKK-1) in the plasma of patients with rheumatoid arthritis (RA), and to analyze their correlation with peripheral blood T cell subsets and clinical indicators.@*METHODS@#Enzyme-linked immunosorbent assay (ELISA) was used to detect plasma DKK-1 levels in 32 RA patients and 20 healthy controls, and to record the various clinical manifestations and laboratory indicators of the RA patients, and flow cytometry to detect peripheral blood T cell subsets in the RA patients (Including Treg, nTreg, aTreg, sTreg, Teff, Tfh, CD4+CD161+T, CD8+T, CD8+CD161+T cells). The plasma DKK-1 levels between the two groups were ompared, and its correlation with peripheral blood T cell subsets and clinical indicators analyzed.@*RESULTS@#(1) The plasma DKK-1 concentration of the RA patients was (124.97±64.98) ng/L. The plasma DKK-1 concentration of the healthy control group was (84.95±13.74) ng/L. The plasma DKK-1 level of the RA patients was significantly higher than that of the healthy control group (P < 0.05), and the percentage of CD8+CD161+T cells in the peripheral blood of the RA patients was significantly higher than that of the healthy control group (P < 0.05). (2) The plasma DKK-1 level was positively correlated with erythrocyte sedimentation rate (r=0.406, P=0.021), DAS28 score (r=0.372, P=0.036), immunoglobulin G(r=0.362, P=0.042), immunoglobulin A(r=0.377, P=0.033); it had no correlation with age, course of disease, C-reactive protein, rheumatoid factor, anti-cyclic citrullinated peptide antibody, immunoglobulin M, complement C3, complement C4, white blood cell, neutrophil ratio. (3) The plasma DKK-1 level in the RA patients was positively correlated with the percentage of peripheral blood CD161+CD8+T cells (r=0.413, P=0.019);it had no correlation with Treg, nTreg, aTreg, sTreg, Teff, Tfh, CD4+CD161+T, CD8+T cells. (4) The percentage of CD161+CD8+T cells was negatively correlated with erythrocyte sedimentation rate (r=-0.415, P=0.004), C-reactive protein (r=-0.393, P=0.007), DAS28 score(r=-0.392, P=0.007), rheumatoid factor (r=-0.535, P < 0.001), anti-citrullinated protein antibody (r=-0.589, P < 0.001), immunoglobulin G(r=-0.368, P=0.012) immunoglobulin M (r=-0.311, P=0.035); it had no correlation with age, disease course, immunoglobulin A, complement C3, complement C4, white blood cell, and neutrophil ratio.@*CONCLUSION@#RA patients' plasma DKK-1 levels and the percentage of CD8+CD161+T cells in T cell subsets in peripheral blood increase, which may be related to the secretion of proinflammatory cytokines in patients; DKK-1 is involved in the regulation of bone homeostasis and can be used as a marker of bone destruction in RA.
الموضوعات
Humans , Arthritis, Rheumatoid , Blood Sedimentation , Intercellular Signaling Peptides and Proteins/blood , Plasma , Rheumatoid Factor , T-Lymphocyte Subsetsالملخص
Sjögren's syndrome is a chronic autoimmune disease, characterized by the presence of hyposalivation and xerophthalmia, which in addition to other factors is diagnosed by the presence of rheumatoid factor in blood. The objective of the present study is to evaluate the presence of rheumatoid factor (IgG-IgM) in the saliva of patients with primary and secondary Sjögren's syndrome. Materials and methods: Forty samples from patients with primary and secondary Sjögren's syndrome previously diagnosed by the Arthritis and Rheumatism Specialist Center of the Autonomous University of Nuevo Leon were analyzed. Samples were taken from the saliva using the Carlson-Crittenden device to evaluate the IgG-IgM immunocomplex using the ELISA method. Results: No significant difference was found between the presence of IgM in primary (0.099±0.016) and secondary Sjögren syndrome (0.098±0.017), however, a high presence of IgG was found in the group of patients with secondary Sjögren's syndrome (0.134±0.054). Conclusion: The search for diagnostic tools using salivary biomarkers has come with economic and clinical advantages, however, in the present study no significant changes were found in salivary rheumatoid factor between both groups.
El síndrome de Sjögren es una enfermedad autoinmune crónica, caracterizada por la presencia de hiposalivación y xeroftalmia, la cual además de otros factores es diagnosticada por la presencia del factor reumatoide en sangre. El objetivo del presente estudio es evaluar la presencia del factor reumatoide (IgG-IgM) en saliva parotídea de pacientes con síndrome de Sjögren primario y secundario. Materiales y métodos: Se analizaron 40 muestras de pacientes con síndrome de Sjögren primario y secundario previamente diagnosticados por el Centro de Especialistas en Artritis y Reumatismo de la Universidad Autónoma de Nuevo León, a los cuales se les tomó una muestra de saliva parotídea mediante el dispositivo Carlson-Crittenden para evaluar mediante el método ELISA el inmunocomplejo IgG-IgM. Resultados: No se encontró diferencia significativa entre la presencia de IgM en el síndrome de Sjögren primario (0.099±0.016) y secundario (0,098±0,017), sin embargo en cuanto a la presencia de la IgG se encontró elevada en el grupo de pacientes con síndrome de Sjögren secundario (0,134±0,054). Conclusión: La búsqueda de herramientas diagnósticas mediante biomarcadores salivales ha traído consigo ventajas económicas y clínicas, sin embargo en el presente estudio no se encontró un cambio significativo en el factor reumatoide salival entre ambos grupos.
الموضوعات
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Rheumatoid Factor , Sjogren's Syndrome/classification , Sjogren's Syndrome/diagnosis , Saliva/metabolism , Secretory Rate , Xerostomia , Cross-Sectional Studies , Mexicoالملخص
Rheumatoid arthritis is a clinical autoimmune syndrome that causes joint damage. The positive or negative anti-cyclic citrullinated protein (CCP) antibodies serodiagnosis differentiates two subsets of the disease, each with different genetic background. Previous studies have identified associations between KIR genes and rheumatoid arthritis but not with anti-CCP serodiagnosis. Therefore, we investigated the proportion of patients seropositive and seronegative to anti-CCP and its possible association with KIR (killer cell immunoglobulin-like receptor) genes. We included 100 patients with rheumatoid arthritis from western Mexico, who were determined for anti-CCP serodiagnosis by ELISA, and 16 KIR genes were genotyped by PCR-SSP. The proportion of seropositive anti-CCP patients was 83%, and they presented a higher frequency of KIR2DL2 genes than the seronegative group (73.6% vs. 46.2%, p = 0.044) which, in turn, presented a higher KIR2DL2-/ KIR2DL3+ genotype frequency than the first ones (46.2% vs. 17.2%, p = 0.043). These results suggest different KIR genetic backgrounds for each subset of the disease according to anti-CCP serodiagnosis.
La artritis reumatoide es un síndrome clínico autoinmune que causa daño en las articulaciones. El serodiagnóstico positivo o negativo para anticuerpos proteicos anti-cíclicos citrulinados (CCP) diferencia dos subconjuntos de la enfermedad, cada uno con diferente fondo genético. Estudios previos han identificado asociaciones entre los genes killer cell immunoglobulin- like receptor (KIR) y la artritis reumatoide, pero no con el serodiagnóstico de anti-CCP. Por lo tanto, investigamos la proporción de seropositividad y seronegatividad anti-CCP y su posible asociación con genes KIR. Se incluyeron 100 pacientes con artritis reumatoide del occidente de México, a quienes se les determinó su serodiagnóstico anti-CCP por ELISA y también se les realizó genotipificación de 16 genes KIR por PCR-SSP. La proporción de pacientes seropositivos anti-CCP fue del 83% y presentaron una mayor frecuencia génica KIR2DL2 que el grupo seronegativo (73.6% vs. 46.2%, p = 0.044), estos últimos presentaron mayor frecuencia genotípica KIR2DL2-/KIR2DL3+ que los primeros (46.2% vs. 17.2%, p = 0.043). Los resultados sugieren diferente fondo genético KIR para cada subconjunto de la enfermedad, de acuerdo con el serodiagnóstico anti-CCP.
الموضوعات
Humans , Male , Female , Adult , Middle Aged , Aged , Arthritis, Rheumatoid/diagnosis , Autoantibodies/blood , Receptors, KIR2DL2/genetics , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/blood , Rheumatoid Factor/blood , Autoantibodies/genetics , Genotype , Mexicoالملخص
BACKGROUND: Several factors, including clinical manifestations and laboratory data, have been used to evaluate the disease activity of Sjögren's syndrome (SS). We investigated saliva indicators of disease activity in primary SS patients. METHODS: We enrolled 138 Taiwanese patients with primary SS and 100 Taiwanese normal controls. Interleukin (IL)-6, IL-17A, tumor necrosis factor-alpha (TNF-α), and rheumatoid factor (RF)-IgA levels in saliva samples were measured using ELISA or fluorescent enzyme-linked immunoassay. Serum IgG, IgA, and IgM levels were measured by nephelometry. Erythrocyte sedimentation rate (ESR) was measured with an automatic ESR analyzer. The t-test and Pearson correlation test were used. RESULTS: IL-6 level was higher in primary SS patients than in normal controls (14.23±14.77 vs 9.87±7.32, P=0.012), but there were no significant differences in IL-17A, TNF-α, and RF-IgA levels. In primary SS patients, IL-6 level correlated weakly with ESR and IgG levels (r=0.252, P=0.015, and r=0.248, P=0.017, respectively), and TNF-α level correlated weakly with IgG level (r=0.231, P=0.024). CONCLUSIONS: IL-6 may play a role in SS pathogenesis. Saliva IL-6 might be an indicator of disease activity in primary SS patients.
الموضوعات
Humans , Blood Sedimentation , Enzyme-Linked Immunosorbent Assay , Immunoassay , Immunoglobulin A , Immunoglobulin G , Immunoglobulin M , Interleukin-17 , Interleukin-6 , Interleukins , Nephelometry and Turbidimetry , Rheumatoid Factor , Saliva , Tumor Necrosis Factor-alphaالملخص
OBJECTIVE: This cross-sectional study aimed to investigate the association between rheumatoid factor (RF) positivity and bone mineral density (BMD) in male Korean subjects without any history of joint disease. METHODS: Of 84,344 males who had undergone a comprehensive health checkup program in 2012, 1,390 male health examinees were recruited, whose BMD and RF results were available. A RF titer ≥20 IU/mL was considered positive. BMD was measured at lumbar spine (L1~L4) or hip (femoral neck and total hip) by dual-energy X-ray absorptiometry. RESULTS: The association between RF positivity and BMD was assessed by multiple linear regression analysis. The mean age was 52.7±10.9 years (range 19~88 years), and RF was detected in 64 subjects (4.6%). Demographics and laboratory data were not different between RF-positive and -negative subjects except hepatitis B surface antigen (HBsAg), which was more frequently seen in RF-positive subjects (15.6% vs. 4.3%, p=0.001). RF-positive subjects had significantly lower BMD compared to RF-negative subjects in lumbar spine but not in total hip regardless of the existence of HBsAg (1.17±0.16 g/cm2 vs. 1.10±0.18 g/cm2, p=0.002 in total subjects; 1.17±0.16 g/cm2 vs. 1.10±0.18 g/cm2, p=0.004 in HBsAg-negative subjects). After adjusting for multiple confounders, RF positivity was negatively associated with lumbar spine BMD (B=−0.088 and standard error=0.035, p=0.011). CONCLUSION: Our results show that the presence of RF could have an unfavorable impact on bone density in apparently normal males. Additional studies to elucidate the osteoimmunological mechanism of rheumatoid factor are warranted.
الموضوعات
Humans , Male , Absorptiometry, Photon , Arthritis , Bone Density , Cross-Sectional Studies , Demography , Hepatitis B Surface Antigens , Hip , Joint Diseases , Linear Models , Men's Health , Neck , Rheumatoid Factor , Spineالملخص
BACKGROUND: Rheumatoid factor (RF) is used as one of the diagnostic criteria for rheumatoid arthritis. The purpose of this study was to evaluate qualitative RF reagents used in clinical laboratories in Korea, and to provide basic data that can be used as a reference to improve the quality of RF testing. METHODS: We reviewed the proficiency testing results for RF from the Korean Association of External Quality Assessment Service (KEQAS) and College of American Pathologists. Moreover, we evaluated five commercially available RF qualitative reagents, including LabSlide RF (IVD Lab Co., Korea), ASAN RA Latex Reagents (Asan Pharmaceuticals Co., Korea), RaPET RF (Stanbio Laboratory, USA), RF Latex Test (Pulse Scientific Inc., Canada), and RF-100 (Teco Diagnostics, USA). Commercially available quality control materials, calibrators, and pooled sera were used in this study. The consistency of qualitative reagents and Kappa statistics were calculated based on the quantitative values of the quality control materials and the mixed sera. RESULTS: Up to 51.5% of high concentration samples were reported as negative in KEQAS. RF qualitative reagent test results were not consistent among reagent types. The consistency of the qualitative and quantitative test results was between 51% and 100%, and the kappa statistics varied depending on the reagent manufacturer. CONCLUSIONS: Measurement of RF qualitative reagents used in domestic clinical laboratories was not consistent with the quantitative values, and hence it is necessary to improve the consistency and verify the adequacy of the cut-off value.
الموضوعات
Arthritis, Rheumatoid , Indicators and Reagents , Korea , Latex , Quality Control , Rheumatoid Factorالملخص
PURPOSE: To investigate the correlation between the tenosynovitis pattern on two-phase bone scintigraphy (2P-BS) and clinical manifestation in patients with suspected rheumatoid arthritis (RA).METHOD: 2P-BS including technetium-99m-methylene diphosphonate blood pool and bone phase imaging in 402 consecutive patients with clinically suspected RAwere retrospectively reviewed. According to 2010 RA Classification Criteria, patients were grouped as RA and non-RA. Visual assessment of all fingers, toes, wrists, and ankles on 2P-BS was performed. Clinical suspected tenosynovitis was evaluated on physical examination. Rheumatoid factor, anti-cyclic citrullinated protein antibody, C-reactive protein, and estimated sedimentation rate were obtained. Radiographic findings were also used to define early and established arthritis.RESULTS: Tenosynovitis pattern was detected in 12.7%(51/402 patients) on 2P-BS.A total of 94.1%(48/51) were diagnosed as RA vs. 5.9% (3/51) as non-RA. Of the 48 RA patients with positive 2P-BS finding, 85.4% (41/48) had early arthritis and 14.6% (7/48) had established arthritis. On physical examination, tenosynovitis was suspected in 21.9% (88/402). A total of 56.8% (50/88) belonged to the RA group and 43.2% (38/88) to the non-RA group. The tenosynovitis pattern of 2P-BS and physical examination showed statistical difference and moderate agreement. The positive tenosynovitis pattern on 2P-BS represented up to 26.408 of odds ratio which was highest among the RA-associated factors.CONCLUSION: Tenosynovitis pattern on 2P-BS was more commonly detected in the RA group and was more frequently associated with early arthritis pattern. Therefore, 2P-BS could give additional information for the detection of subclinical tenosynovitis in early or preclinical RA patients.
الموضوعات
Humans , Ankle , Arthritis , Arthritis, Rheumatoid , C-Reactive Protein , Classification , Fingers , Methods , Odds Ratio , Physical Examination , Radionuclide Imaging , Retrospective Studies , Rheumatoid Factor , Tenosynovitis , Toes , Wristالملخص
Introduction : En Afrique Sub-saharienne, les rhumatismes inflammatoires chroniques sont des affections peu rapportées chez l'enfant. Objectif : Contribuer à la connaissance des rhumatismes inflammatoires chroniques chez l'enfant Patients et Méthodes : Le service de Rhumatologie du CHU de Brazzaville a mis en place depuis janvier 2012, une consultation spécialisée des maladies auto immunes et des systèmes. La filière active compte 90 patients. De celle-ci sont extraits cinq dossiers de patients âgés de moins de 18 ans. Leurs données épidémiologiques, cliniques, para cliniques et évolutifs ont été colligés pour en faire ressortir les particularités éventuelles. Résultats : Il s'agissait de 3 filles et 2 garçons âgés de 8 ans à 16 ans suivis depuis 38 mois en moyenne (extrême de 33 à 42 mois). La douleur articulaire était le principal motif de consultation. Elle intéressait principalement les grosses et petites articulations des membres, d'horaire inflammatoire. Il existait une altération de l'état général dans 3 cas. Les signes de synovites étaient présents à l'examen physique. Il existait un syndrome inflammatoire biologique dans trois cas. Le bilan auto immun (FR, Ac anticcp, AAN, Ac anti DNA, ANCA) a été réalisé chez quatre patients. Les diagnostics retenus étaient l'arthrite juvénile idiopathique dans deux cas, sclérodermie systémique, connectivite mixte et la maladie de Still et dans 1 cas chacun. Tous ont bénéficié d'une corticothérapie et d'un traitement de fond. Trois enfants sont en rémission, deux autres sont contrôlés. Un seul cas d'intolérance a été observé (rash cutané sous plaquenil). Conclusion : Affection peu fréquente. Le diagnostic repose sur une démarche clinico-biologique et une approche pluridisciplinaire, gage d'un traitement efficace et bien toléré